Chainalysis stock $5.95 USD

Private-market facts for current and former Chainalysis employees researching their stock.

Latest Round
Series F
Valuation
$2B
Founded
2014
Headquarters
New York, NY
Founders
Michael Gronager, Jonathan Levin
Status
private

Price per share sourced from public secondary-market data. Updated April 2026. Indicative only — not a live quote.

Talk to a Chainalysis stock specialist

Get personalized guidance on your Chainalysis shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Overview

Chainalysis provides blockchain analytics and compliance tools that help government agencies, financial institutions, and cryptocurrency businesses investigate illicit transactions and meet regulatory requirements.

Chainalysis outlook

Equity outlook100% data confidence
1x
Base scenario
2x
Upside scenario

For employees evaluating Chainalysis equity, a 1x base multiple suggests the stock may be close to fairly valued at current prices. The upside scenario at 2x is relatively close to the base case, suggesting more predictable but narrower range of outcomes.

These estimates reflect modeled return scenarios, not guaranteed outcomes. Actual results depend on company performance, market conditions, share class, and timing.

Illustrative model · v1.0.0 · Not investment advice

Selling Chainalysis shares

Why shareholders consider selling

Shareholders in Chainalysis may explore liquidity for a number of reasons — diversifying a concentrated position, funding a personal financial goal, or simply reducing exposure to a single private holding. As a private company, Chainalysis does not trade on a public exchange, meaning employees and early shareholders cannot simply sell through a brokerage. Extended private timelines can leave shareholders waiting years for an exit event, which is why some choose to explore secondary-market options.

Can you sell Chainalysis stock?

Whether a shareholder can sell typically depends on what they hold and how it was acquired. Vested and exercised shares are generally more straightforward than unexercised options or unvested RSUs. Most private companies, including those in the Blockchain & Web3 sector, impose transfer restrictions such as rights of first refusal or board approval requirements. The specific terms governing Chainalysis shares would be outlined in the holder's equity agreement or the company's governing documents.

What affects the value of Chainalysis shares?

The price a buyer is willing to pay for private shares is shaped by several factors: overall demand for the stock, the company's financial performance, broader Blockchain & Web3 market conditions, and any recent private-market transaction activity. Data points such as the company's Series F round, its reported $2B valuation and recent secondary-market pricing can help frame expectations, though they do not guarantee a transaction price.

What should holders check before selling

  • The type of security held (common shares, preferred, options, RSUs)
  • Whether the equity is fully vested and, for options, whether it has been exercised
  • Any transfer restrictions, lock-up provisions, or company approval requirements
  • Estimated net proceeds after applicable taxes and transaction fees
  • Whether partial liquidity — selling a portion rather than the full position — may be a better fit

Tools for Chainalysis shareholders

Exploring equity in Chainalysis often raises questions about taxes, exercise timing, valuation, and exit outcomes. These tools can help you model different decisions using your own assumptions.

Latest funding round

Chainalysis most recently raised a Series F round in June 2022. The company was valued at $2B. Total funding raised to date is approximately $537M.

Lead investors in this round include Benchmark and Accel.

Founders & company background

Chainalysis was founded in 2014 by Michael Gronager, Jonathan Levin and is headquartered in New York, NY.

Investors

Industry

Similar private companies

Latest Chainalysis news

Talk to a Chainalysis stock specialist

Get personalized guidance on your Chainalysis shares — including current market activity, pricing context, and liquidity options.

Speak with an expert

Frequently asked questions

Is Chainalysis still a private company?
Yes, Chainalysis is currently a private company.
What is Chainalysis's latest funding round?
Chainalysis's most recent known round is Series F, raised in June 2022.
What is Chainalysis's valuation?
Chainalysis's latest reported valuation is $2B.
Who are the investors in Chainalysis?
Notable investors include Benchmark, Accel, GIC, Blackstone Group, Ribbit Capital.
Can I sell my Chainalysis stock?
Private company shares can sometimes be sold on secondary markets. Speaking with a specialist who understands Chainalysis stock can help you evaluate your options.

Related pages

Last verified: 2026-04-13 · Chainalysis data compiled from funding disclosures, investor announcements, corporate filings, and public records.

Information on this page is compiled from publicly available sources and may be outdated or incomplete. This is not investment advice. Consult a qualified advisor before making financial decisions.